Aberrant expression of the COX2/PGE2 axis is induced by activation of the RAF/MEK/ERK pathway in BRAFV595E canine urothelial carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aberrant expression of the COX2/PGE2 axis is induced by activation of the RAF/MEK/ERK pathway in BRAFV595E canine urothelial carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-08
DOI
10.1038/s41598-020-64832-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of Human Epidermal Growth Factor Receptor 2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder
- (2019) Masaya Tsuboi et al. VETERINARY PATHOLOGY
- Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial
- (2019) Keisuke Kosumi et al. EUROPEAN JOURNAL OF CANCER
- Anti-tumor effects of the histone deacetylase inhibitor vorinostat on canine urothelial carcinoma cells
- (2019) Shotaro Eto et al. PLoS One
- GREIN: An Interactive Web Platform for Re-analyzing GEO RNA-seq Data
- (2019) Naim Al Mahi et al. Scientific Reports
- Overexpression of COX2 indicates poor survival in urothelial bladder cancer
- (2018) Usha Agrawal et al. Annals of Diagnostic Pathology
- Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq
- (2018) Shingo Maeda et al. BMC CANCER
- AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status
- (2018) Rui Ma et al. BRITISH JOURNAL OF CANCER
- Anti-tumour effect of lapatinib in canine transitional cell carcinoma cell lines
- (2018) Kosei Sakai et al. Veterinary and Comparative Oncology
- Molecular investigation of the direct anti-tumour effects of nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell lines
- (2017) R. Yoshitake et al. VETERINARY JOURNAL
- Senescent tumor cells lead the collective invasion in thyroid cancer
- (2017) Young Hwa Kim et al. Nature Communications
- ERK2 and JNK1 contribute to TNF-α-induced IL-8 expression in synovial fibroblasts
- (2017) Shinichi Namba et al. PLoS One
- Negative feedback regulation of the ERK1/2 MAPK pathway
- (2016) David Lake et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic Test
- (2015) B. Decker et al. MOLECULAR CANCER RESEARCH
- Management of transitional cell carcinoma of the urinary bladder in dogs: A review
- (2015) Christopher M. Fulkerson et al. VETERINARY JOURNAL
- Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies
- (2014) S. Venderbosch et al. CLINICAL CANCER RESEARCH
- Differences in Expression of Uroplakin III, Cytokeratin 7, and Cyclooxygenase-2 in Canine Proliferative Urothelial Lesions of the Urinary Bladder
- (2014) D. G. Sledge et al. VETERINARY PATHOLOGY
- Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor
- (2013) T M Becker et al. ONCOGENE
- Wnt signaling potentiates nevogenesis
- (2013) J. S. Pawlikowski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BRAFV600Eremodels the melanocyte transcriptome and inducesBANCRto regulate melanoma cell migration
- (2012) Ross J. Flockhart et al. GENOME RESEARCH
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year Update
- (2012) John M. Kyriakis et al. PHYSIOLOGICAL REVIEWS
- COX2 overexpression is a prognostic marker for Stage III breast cancer
- (2011) Hee Sung Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Overexpression of cyclooxygenase-2 in NCI-H292 human alveolar epithelial carcinoma cells: Roles of p38 MAPK, ERK-1/2, and PI3K/PKB signaling proteins
- (2011) Suhaeng Sung et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Signal pathways JNK and NF-κB, identified by global gene expression profiling, are involved in regulation of TNFα-induced mPGES-1 and COX-2 expression in gingival fibroblasts
- (2010) Tove Båge et al. BMC GENOMICS
- COX-2 expression and outcome in canine nasal carcinomas treated with hypofractionated radiotherapy*†
- (2010) Z. Belshaw et al. Veterinary and Comparative Oncology
- HGF/Met signalling promotes PGE2 biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells
- (2009) A. E. Moore et al. CARCINOGENESIS
- The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
- (2009) A. Greenhough et al. CARCINOGENESIS
- Oncogenic K-Ras Regulates Proliferation and Cell Junctions in Lung Epithelial Cells through Induction of Cyclooxygenase-2 and Activation of Metalloproteinase-9
- (2008) Xue-Qing Wang et al. MOLECULAR BIOLOGY OF THE CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now